Adlakha R C, Ashorn C L, Chan D, Zwelling L A
Department of Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
Cancer Res. 1989 Apr 15;49(8):2052-8.
Our earlier studies have shown that gossypol [1,1',6,6',7,7'-hexahydroxy-5,5-diisopropyl - 3,3'-dimethyl - (2,2'- binaphthalene)-8,8'-dicarboxyaldehyde], a male contraceptive, inhibits DNA synthesis by decreasing the activities of DNA polymerase alpha and beta, resulting in the arrest of cells in mid-S phase [L.J. Rosenberg, R.C. Adlakha, D.M. Desai, and P.N. Rao, Biochim. Biophys. Acta, 866: 258-267, 1986]. Now we have examined the effects of gossypol on another enzyme of importance to cellular functions, topoisomerase II (topo II). We have determined the consequences of gossypol treatment on 4'-(9-acridinylamino)methane-sulfon-m anisidide (m-AMSA)-induced topoisomerase II-mediated, protein-associated DNA cleavage using the alkaline elution technique. In HeLa cells pretreated with gossypol (3.4-17.5 microM) for 8-16 h we observed a dose- and time-dependent decrease (50-75%) in DNA cleavage compared to that quantified in cells treated with m-AMSA alone. Gossypol by itself did not induce more than 25 rad-equivalents of DNA single-strand breaks even at the highest dose tested (26 microM). [14C]m-AMSA uptake was identical in treated and untreated cells. Pretreatment of cells with another inhibitor of DNA synthesis, thymidine, which blocks cells at G1/S boundary increased the m-AMSA-induced DNA cleavage by 25%, suggesting that the effect of gossypol might be due to the arrest of cells in mid-S phase. In contrast to gossypol's effects on m-AMSA-induced DNA cleavage, m-AMSA-induced cytotoxicity was actually increased in gossypol pretreated cells. Gossypol blocked topo II strand passing activity (decatenation of kinetoplast DNA) of cellular extracts from HeLa cells. The inhibition of this activity by gossypol was synergistic with the inhibition produced by m-AMSA or etoposide. These data suggest that gossypol can both inhibit topo II catalytic activity and interfere with the stabilization of topo II-DNA complex formation by m-AMSA. These data indicate that the magnitude of m-AMSA-induced DNA cleavage may not necessarily parallel the magnitude of m-AMSA-induced cytotoxicity. The cytotoxicity data may rather be explained by an action of gossypol and m-AMSA to block topo II catalytic activity at a point in the enzyme's strand passing cycle prior to cleavage complex formation that might be particularly toxic to cells in S phase. Gossypol should therefore be useful in improving our understanding of the cellular role of topo II and the consequences of interference with topo II activity by active antineoplastic agents.
我们早期的研究表明,棉酚[1,1',6,6',7,7'-六羟基-5,5-二异丙基-3,3'-二甲基-(2,2'-联萘)-8,8'-二羧酸二醛],一种男性避孕药,通过降低DNA聚合酶α和β的活性来抑制DNA合成,导致细胞停滞在S期中期[L.J.罗森伯格、R.C.阿德拉克哈、D.M.德赛和P.N.拉奥,《生物化学与生物物理学报》,866:258 - 267,1986]。现在我们研究了棉酚对另一种对细胞功能很重要的酶——拓扑异构酶II(topo II)的影响。我们使用碱性洗脱技术确定了棉酚处理对4'-(9-吖啶基氨基)甲磺酰基-m-茴香胺(m-AMSA)诱导的拓扑异构酶II介导的、与蛋白质相关的DNA切割的影响。在用棉酚(3.4 - 17.5 microM)预处理8 - 16小时的HeLa细胞中,与仅用m-AMSA处理的细胞相比,我们观察到DNA切割呈剂量和时间依赖性降低(50 - 75%)。即使在测试的最高剂量(26 microM)下,棉酚本身诱导的DNA单链断裂也不超过25拉德当量。[14C]m-AMSA在处理和未处理的细胞中的摄取是相同的。用另一种DNA合成抑制剂胸苷预处理细胞,胸苷可将细胞阻滞在G1/S边界,这使m-AMSA诱导的DNA切割增加了25%,表明棉酚的作用可能是由于细胞停滞在S期中期。与棉酚对m-AMSA诱导的DNA切割的影响相反,在棉酚预处理的细胞中,m-AMSA诱导的细胞毒性实际上增加了。棉酚阻断了HeLa细胞提取物中topo II的链通过活性(动质体DNA的解连环)。棉酚对这种活性的抑制与m-AMSA或依托泊苷产生的抑制具有协同作用。这些数据表明,棉酚既能抑制topo II的催化活性,又能干扰m-AMSA形成topo II - DNA复合物的稳定性。这些数据表明,m-AMSA诱导的DNA切割程度不一定与m-AMSA诱导的细胞毒性程度平行。细胞毒性数据可能更多地是由棉酚和m-AMSA在酶的链通过循环中切割复合物形成之前的一点上阻断topo II催化活性的作用来解释的,这可能对S期的细胞特别有毒。因此,棉酚应有助于增进我们对topo II在细胞中的作用以及活性抗肿瘤药物干扰topo II活性的后果的理解。